Latest Insider Transactions at Bio Cor Rx Inc. (BICX)
This section provides a real-time view of insider transactions for Bio Cor Rx Inc. (BICX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioCorRx Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioCorRx Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
44,220
+3.44%
|
-
|
|
Jun 28
2024
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
10,204
+13.72%
|
-
|
|
Jun 28
2024
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,204
+10.12%
|
-
|
|
May 31
2024
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
22,831
+3.8%
|
-
|
|
Apr 30
2024
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
21,552
+3.73%
|
-
|
|
Mar 28
2024
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
5,566
+9.35%
|
-
|
|
Mar 28
2024
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
5,566
+2.29%
|
-
|
|
Mar 28
2024
|
Harsha Murthy |
BUY
Grant, award, or other acquisition
|
Direct |
5,566
+22.01%
|
-
|
|
Mar 28
2024
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
24,119
+2.21%
|
-
|
|
Mar 28
2024
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,566
+6.48%
|
-
|
|
Feb 29
2024
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
16,892
+3.21%
|
-
|
|
Jan 31
2024
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
18,269
+3.57%
|
-
|
|
Jan 16
2024
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
126
+0.03%
|
$0
$0.7 P/Share
|
|
Jan 12
2024
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
3,000
+0.63%
|
$0
$0.7 P/Share
|
|
Jan 02
2024
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
6,173
+2.59%
|
-
|
|
Jan 02
2024
|
Harsha Murthy |
BUY
Grant, award, or other acquisition
|
Direct |
6,173
+30.37%
|
-
|
|
Jan 02
2024
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
6,173
+7.62%
|
-
|
|
Jan 02
2024
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
6,173
+1.29%
|
-
|
|
Jan 02
2024
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
6,173
+11.31%
|
-
|
|
Sep 29
2023
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+2.44%
|
-
|
|
Sep 29
2023
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+1.25%
|
-
|
|
Sep 29
2023
|
Harsha Murthy |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+26.37%
|
-
|
|
Sep 29
2023
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+6.34%
|
-
|
|
Sep 29
2023
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+0.61%
|
-
|
|
Sep 29
2023
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+4.0%
|
-
|
|
Jun 30
2023
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
2,891
+1.28%
|
-
|
|
Jun 30
2023
|
Harsha Murthy |
BUY
Grant, award, or other acquisition
|
Direct |
2,891
+36.08%
|
-
|
|
Jun 30
2023
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
2,891
+2.53%
|
-
|
|
Jun 30
2023
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,891
+4.21%
|
-
|
|
Jun 30
2023
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
2,891
+0.62%
|
-
|
|
Jun 30
2023
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
2,891
+6.84%
|
-
|
|
Apr 03
2023
|
Louis C. Lucido President |
BUY
Other acquisition or disposition
|
Direct |
183,606
+28.53%
|
-
|
|
Apr 03
2023
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Indirect |
171,296
+38.27%
|
$171,296
$1.75 P/Share
|
|
Mar 31
2023
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
2,824
+1.27%
|
-
|
|
Mar 31
2023
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
2,824
+2.54%
|
-
|
|
Mar 31
2023
|
Harsha Murthy |
BUY
Grant, award, or other acquisition
|
Direct |
2,231
+50.0%
|
-
|
|
Mar 31
2023
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
2,824
+7.18%
|
-
|
|
Mar 31
2023
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,824
+4.3%
|
-
|
|
Mar 31
2023
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
2,824
+2.62%
|
-
|
|
Mar 29
2023
|
Joseph J Galligan |
BUY
Open market or private purchase
|
Indirect |
171,296
+44.05%
|
$171,296
$1.75 P/Share
|
|
Jan 30
2023
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
400
+0.2%
|
$400
$1.38 P/Share
|
|
Jan 26
2023
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
500
+0.49%
|
$500
$1.29 P/Share
|
|
Jan 24
2023
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
200
+0.2%
|
$200
$1.2 P/Share
|
|
Jan 13
2023
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
4,000
+1.96%
|
$4,000
$1.13 P/Share
|
|
Jan 03
2023
|
Louis C. Lucido President |
BUY
Open market or private purchase
|
Direct |
2,000
+2.02%
|
$2,000
$1.1 P/Share
|
|
Dec 30
2022
|
Joseph J Galligan |
BUY
Grant, award, or other acquisition
|
Direct |
5,319
+10.31%
|
-
|
|
Dec 30
2022
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct |
5,319
+13.64%
|
-
|
|
Dec 30
2022
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct |
5,319
+4.8%
|
-
|
|
Dec 30
2022
|
Lourdes Felix CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,319
+8.13%
|
-
|
|
Dec 30
2022
|
Louis C. Lucido President |
BUY
Grant, award, or other acquisition
|
Direct |
5,319
+5.3%
|
-
|